<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=875423625897521&amp;ev=PageView&amp;noscript=1">

Sensing Savvy

Clinical Indicators of End-Stage Renal Disease (USRDS) 2018

Posted by Susan Eymann, MS on Dec 4, 2019

(Gleaned from the 2018 USRDS Annual Data Report: Volume II: Chapter 2)

Given the high morbidity and mortality of individuals with end-stage renal disease (ESRD) who are receiving dialysis, quality improvement of renal replacement therapies (RRT) initiatives has long been a priority. Notable efforts from the Centers for Medicare & GettyImages-1132248020Medicaid Services (CMS) include assessment and reporting of provider performance through Dialysis Facility Reports and Dialysis Facility Compare, as well as the Quality Incentive Program (QIP), which ties Medicare reimbursement to the achievement of selected quality targets.

Nevertheless, preventive care for ESRD patients has declined since 2010. In 2010, 36.4 percent of diabetic ESRD patients had comprehensive diabetes monitoring that included an A1c test, lipid exam and a diabetic eye exam. However, by 2016 only 28.8 percent of diabetic ESRD patients received comparable comprehensive diabetes monitoring.

New call-to-action

Healthcare Insights to Improve Results

Sensing Savvy provides you with the  information you need to stay up to date on the latest clinical news and trends, techniques, products and more. Start advancing your outcomes. Subscribe today.

Get Articles and Insights by Email

Recent Posts